- Home
- XELB vs GTBP Comparison
XELB vs GTBP Comparison
Compare XELB & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XELB
- GTBP
- Stock Information
- Founded
- XELB 2011
- GTBP 1965
- Country
- XELB United States
- GTBP United States
- Employees
- XELB N/A
- GTBP N/A
- Industry
- XELB Multi-Sector Companies
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- XELB Miscellaneous
- GTBP Health Care
- Exchange
- XELB Nasdaq
- GTBP Nasdaq
- Market Cap
- XELB 6.0M
- GTBP 5.5M
- IPO Year
- XELB N/A
- GTBP N/A
- Fundamental
- Price
- XELB $2.63
- GTBP $2.23
- Analyst Decision
- XELB
- GTBP Strong Buy
- Analyst Count
- XELB 0
- GTBP 1
- Target Price
- XELB N/A
- GTBP $11.00
- AVG Volume (30 Days)
- XELB 221.9K
- GTBP 17.4K
- Earning Date
- XELB 05-27-2025
- GTBP 05-15-2025
- Dividend Yield
- XELB N/A
- GTBP N/A
- EPS Growth
- XELB N/A
- GTBP N/A
- EPS
- XELB N/A
- GTBP N/A
- Revenue
- XELB $9,337,000.00
- GTBP N/A
- Revenue This Year
- XELB N/A
- GTBP N/A
- Revenue Next Year
- XELB $71.83
- GTBP N/A
- P/E Ratio
- XELB N/A
- GTBP N/A
- Revenue Growth
- XELB N/A
- GTBP N/A
- 52 Week Low
- XELB $2.02
- GTBP $1.72
- 52 Week High
- XELB $8.49
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- XELB 50.79
- GTBP 46.01
- Support Level
- XELB $2.32
- GTBP $2.30
- Resistance Level
- XELB $2.82
- GTBP $2.37
- Average True Range (ATR)
- XELB 0.23
- GTBP 0.15
- MACD
- XELB 0.05
- GTBP -0.01
- Stochastic Oscillator
- XELB 67.87
- GTBP 14.55
About XELB Xcel Brands Inc.
Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.